mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
0.01 |